Global Anti-Peptic Ulcer Drugs Market Growth 2020-2025

  • receipt Report ID : 61118
  • calendar_today Published On: Nov, 2020
  • file_copy Pages: 135
  • list Pharmaceuticals and Healthcare
Buy @ $3660

According to this study, over the next five years the Anti-Peptic Ulcer Drugs market will register a 13.9%% CAGR in terms of revenue, the global market size will reach $ 11060 million by 2025, from $ 6574.3 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Anti-Peptic Ulcer Drugs business, shared in Chapter 3.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-Peptic Ulcer Drugs market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Anti-Peptic Ulcer Drugs, covering the supply chain analysis, impact assessment to the Anti-Peptic Ulcer Drugs market size growth rate in several scenarios, and the measures to be undertaken by Anti-Peptic Ulcer Drugs companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.

Proton Pump Inhibitors (PPIs)

Potassium-Competitive Acid Blockers (P-CAB)

Antacids

H2 Antagonists

Ulcer Protective Drugs

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.

Gastritis

Gastric Ulcers

Duodenal Ulcers

Gastroesophageal Reflux Disease (GERD)

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.

AstraZeneca

Xian Janssen

Ask-pharm

Yangtze River Pharm

Shandong Luoxin

Takeda

Beijing Yuekang

Huadong Medicine

Guangdong Dahua

Changzhou Siyao

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives

To study and analyze the global Anti-Peptic Ulcer Drugs consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.

To understand the structure of Anti-Peptic Ulcer Drugs market by identifying its various subsegments.

Focuses on the key global Anti-Peptic Ulcer Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.

To analyze the Anti-Peptic Ulcer Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.

To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

To project the consumption of Anti-Peptic Ulcer Drugs submarkets, with respect to key regions (along with their respective key countries).

To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

To strategically profile the key players and comprehensively analyze their growth strategies.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

1 Scope of the Report

1.1 Market Introduction

1.2 Research Objectives

1.3 Years Considered

1.4 Market Research Methodology

1.5 Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Anti-Peptic Ulcer Drugs Consumption 2015-2025

2.1.2 Anti-Peptic Ulcer Drugs Consumption CAGR by Region

2.2 Anti-Peptic Ulcer Drugs Segment by Type

2.2.1 Proton Pump Inhibitors (PPIs)

2.2.2 Potassium-Competitive Acid Blockers (P-CAB)

2.2.3 Antacids

2.2.4 H2 Antagonists

2.2.5 Ulcer Protective Drugs

2.3 Anti-Peptic Ulcer Drugs Consumption by Type

2.3.1 Global Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

2.3.2 Global Anti-Peptic Ulcer Drugs Revenue and Market Share by Type (2015-2020)

2.3.3 Global Anti-Peptic Ulcer Drugs Sale Price by Type (2015-2020)

2.4 Anti-Peptic Ulcer Drugs Segment by Application

2.4.1 Gastritis

2.4.2 Gastric Ulcers

2.4.3 Duodenal Ulcers

2.4.4 Gastroesophageal Reflux Disease (GERD)

2.5 Anti-Peptic Ulcer Drugs Consumption by Application

2.5.1 Global Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

2.5.2 Global Anti-Peptic Ulcer Drugs Value and Market Share by Type (2015-2020)

2.5.3 Global Anti-Peptic Ulcer Drugs Sale Price by Type (2015-2020)

3 Global Anti-Peptic Ulcer Drugs by Company

3.1 Global Anti-Peptic Ulcer Drugs Sales Market Share by Company

3.1.1 Global Anti-Peptic Ulcer Drugs Sales by Company (2018-2020)

3.1.2 Global Anti-Peptic Ulcer Drugs Sales Market Share by Company (2018-2020)

3.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Company

3.2.1 Global Anti-Peptic Ulcer Drugs Revenue by Company (2018-2020)

3.2.2 Global Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2018-2020)

3.3 Global Anti-Peptic Ulcer Drugs Sale Price by Company

3.4 Global Anti-Peptic Ulcer Drugs Manufacturing Base Distribution, Sales Area, Type by Company

3.4.1 Global Anti-Peptic Ulcer Drugs Manufacturing Base Distribution and Sales Area by Company

3.4.2 Players Anti-Peptic Ulcer Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 Anti-Peptic Ulcer Drugs by Regions

4.1 Anti-Peptic Ulcer Drugs by Regions

4.2 Americas Anti-Peptic Ulcer Drugs Consumption Growth

4.3 APAC Anti-Peptic Ulcer Drugs Consumption Growth

4.4 Europe Anti-Peptic Ulcer Drugs Consumption Growth

4.5 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Growth

5 Americas

5.1 Americas Anti-Peptic Ulcer Drugs Consumption by Countries

5.1.1 Americas Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020)

5.1.2 Americas Anti-Peptic Ulcer Drugs Value by Countries (2015-2020)

5.2 Americas Anti-Peptic Ulcer Drugs Consumption by Type

5.3 Americas Anti-Peptic Ulcer Drugs Consumption by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

5.8 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Anti-Peptic Ulcer Drugs Consumption by Regions

6.1.1 APAC Anti-Peptic Ulcer Drugs Consumption by Regions (2015-2020)

6.1.2 APAC Anti-Peptic Ulcer Drugs Value by Regions (2015-2020)

6.2 APAC Anti-Peptic Ulcer Drugs Consumption by Type

6.3 APAC Anti-Peptic Ulcer Drugs Consumption by Application

6.4 China

6.5 Japan

6.6 Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 Key Economic Indicators of Few APAC Regions

7 Europe

7.1 Europe Anti-Peptic Ulcer Drugs by Countries

7.1.1 Europe Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020)

7.1.2 Europe Anti-Peptic Ulcer Drugs Value by Countries (2015-2020)

7.2 Europe Anti-Peptic Ulcer Drugs Consumption by Type

7.3 Europe Anti-Peptic Ulcer Drugs Consumption by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa

8.1 Middle East & Africa Anti-Peptic Ulcer Drugs by Countries

8.1.1 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020)

8.1.2 Middle East & Africa Anti-Peptic Ulcer Drugs Value by Countries (2015-2020)

8.2 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Type

8.3 Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers and Impact

9.1.1 Growing Demand from Key Regions

9.1.2 Growing Demand from Key Applications and Potential Industries

9.2 Market Challenges and Impact

9.3 Market Trends

10 Marketing, Distributors and Customer

10.1 Sales Channel

10.1.1 Direct Channels

10.1.2 Indirect Channels

10.2 Anti-Peptic Ulcer Drugs Distributors

10.3 Anti-Peptic Ulcer Drugs Customer

11 Global Anti-Peptic Ulcer Drugs Market Forecast

11.1 Global Anti-Peptic Ulcer Drugs Consumption Forecast (2021-2025)

11.2 Global Anti-Peptic Ulcer Drugs Forecast by Regions

11.2.1 Global Anti-Peptic Ulcer Drugs Forecast by Regions (2021-2025)

11.2.2 Global Anti-Peptic Ulcer Drugs Value Forecast by Regions (2021-2025)

11.2.3 Americas Consumption Forecast

11.2.4 APAC Consumption Forecast

11.2.5 Europe Consumption Forecast

11.2.6 Middle East & Africa Consumption Forecast

11.3 Americas Forecast by Countries

11.3.1 United States Market Forecast

11.3.2 Canada Market Forecast

11.3.3 Mexico Market Forecast

11.3.4 Brazil Market Forecast

11.4 APAC Forecast by Countries

11.4.1 China Market Forecast

11.4.2 Japan Market Forecast

11.4.3 Korea Market Forecast

11.4.4 Southeast Asia Market Forecast

11.4.5 India Market Forecast

11.4.6 Australia Market Forecast

11.5 Europe Forecast by Countries

11.5.1 Germany Market Forecast

11.5.2 France Market Forecast

11.5.3 UK Market Forecast

11.5.4 Italy Market Forecast

11.5.5 Russia Market Forecast

11.6 Middle East & Africa Forecast by Countries

11.6.1 Egypt Market Forecast

11.6.2 South Africa Market Forecast

11.6.3 Israel Market Forecast

11.6.4 Turkey Market Forecast

11.6.5 GCC Countries Market Forecast

11.7 Global Anti-Peptic Ulcer Drugs Forecast by Type

11.8 Global Anti-Peptic Ulcer Drugs Forecast by Application

12 Key Players Analysis

12.1 AstraZeneca

12.1.1 Company Information

12.1.2 Anti-Peptic Ulcer Drugs Product Offered

12.1.3 AstraZeneca Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.1.4 Main Business Overview

12.1.5 AstraZeneca Latest Developments

12.2 Xian Janssen

12.2.1 Company Information

12.2.2 Anti-Peptic Ulcer Drugs Product Offered

12.2.3 Xian Janssen Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.2.4 Main Business Overview

12.2.5 Xian Janssen Latest Developments

12.3 Ask-pharm

12.3.1 Company Information

12.3.2 Anti-Peptic Ulcer Drugs Product Offered

12.3.3 Ask-pharm Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.3.4 Main Business Overview

12.3.5 Ask-pharm Latest Developments

12.4 Yangtze River Pharm

12.4.1 Company Information

12.4.2 Anti-Peptic Ulcer Drugs Product Offered

12.4.3 Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.4.4 Main Business Overview

12.4.5 Yangtze River Pharm Latest Developments

12.5 Shandong Luoxin

12.5.1 Company Information

12.5.2 Anti-Peptic Ulcer Drugs Product Offered

12.5.3 Shandong Luoxin Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.5.4 Main Business Overview

12.5.5 Shandong Luoxin Latest Developments

12.6 Takeda

12.6.1 Company Information

12.6.2 Anti-Peptic Ulcer Drugs Product Offered

12.6.3 Takeda Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.6.4 Main Business Overview

12.6.5 Takeda Latest Developments

12.7 Beijing Yuekang

12.7.1 Company Information

12.7.2 Anti-Peptic Ulcer Drugs Product Offered

12.7.3 Beijing Yuekang Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.7.4 Main Business Overview

12.7.5 Beijing Yuekang Latest Developments

12.8 Huadong Medicine

12.8.1 Company Information

12.8.2 Anti-Peptic Ulcer Drugs Product Offered

12.8.3 Huadong Medicine Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.8.4 Main Business Overview

12.8.5 Huadong Medicine Latest Developments

12.9 Guangdong Dahua

12.9.1 Company Information

12.9.2 Anti-Peptic Ulcer Drugs Product Offered

12.9.3 Guangdong Dahua Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.9.4 Main Business Overview

12.9.5 Guangdong Dahua Latest Developments

12.10 Changzhou Siyao

12.10.1 Company Information

12.10.2 Anti-Peptic Ulcer Drugs Product Offered

12.10.3 Changzhou Siyao Anti-Peptic Ulcer Drugs Sales, Revenue, Price and Gross Margin (2018-2020)

12.10.4 Main Business Overview

12.10.5 Changzhou Siyao Latest Developments

13 Research Findings and Conclusion

List of Tables

Table 1. Research Methodology

Table 2. Data Source

Table 3. Anti-Peptic Ulcer Drugs Consumption CAGR by Region 2015-2025 ($ Millions)

Table 4. Major Players of Proton Pump Inhibitors (PPIs)

Table 5. Major Players of Potassium-Competitive Acid Blockers (P-CAB)

Table 6. Major Players of Antacids

Table 7. Major Players of H2 Antagonists

Table 8. Major Players of Ulcer Protective Drugs

Table 9. Global Consumption Sales by Type (2015-2020)

Table 10. Global Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

Table 11. Global Anti-Peptic Ulcer Drugs Revenue by Type (2015-2020) ($ million)

Table 12. Global Anti-Peptic Ulcer Drugs Value Market Share by Type (2015-2020) ($ Millions)

Table 13. Global Anti-Peptic Ulcer Drugs Sale Price by Type (2015-2020)

Table 14. Global Consumption Sales by Application (2015-2020)

Table 15. Global Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2015-2020)

Table 16. Global Anti-Peptic Ulcer Drugs Value by Application (2015-2020)

Table 17. Global Anti-Peptic Ulcer Drugs Value Market Share by Application (2015-2020)

Table 18. Global Anti-Peptic Ulcer Drugs Sale Price by Application (2015-2020)

Table 19. Global Anti-Peptic Ulcer Drugs Sales by Company (2017-2019) (K MT)

Table 20. Global Anti-Peptic Ulcer Drugs Sales Market Share by Company (2017-2019)

Table 21. Global Anti-Peptic Ulcer Drugs Revenue by Company (2017-2019) ($ Millions)

Table 22. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Company (2017-2019)

Table 23. Global Anti-Peptic Ulcer Drugs Sale Price by Company (2017-2019)

Table 24. Global Anti-Peptic Ulcer Drugs Manufacturing Base Distribution and Sales Area by Manufacturers

Table 25. Players Anti-Peptic Ulcer Drugs Products Offered

Table 26. Anti-Peptic Ulcer Drugs Concentration Ratio (CR3, CR5 and CR10) (2017-2019)

Table 27. Global Anti-Peptic Ulcer Drugs Consumption by Regions 2015-2020 (K MT)

Table 28. Global Anti-Peptic Ulcer Drugs Consumption Market Share by Regions 2015-2020

Table 29. Global Anti-Peptic Ulcer Drugs Value by Regions 2015-2020 ($ Millions)

Table 30. Global Anti-Peptic Ulcer Drugs Value Market Share by Regions 2015-2020

Table 31. Americas Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020) (K MT)

Table 32. Americas Anti-Peptic Ulcer Drugs Consumption Market Share by Countries (2015-2020)

Table 33. Americas Anti-Peptic Ulcer Drugs Value by Countries (2015-2020) ($ Millions)

Table 34. Americas Anti-Peptic Ulcer Drugs Value Market Share by Countries (2015-2020)

Table 35. Americas Anti-Peptic Ulcer Drugs Consumption by Type (2015-2020) (K MT)

Table 36. Americas Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

Table 37. Americas Anti-Peptic Ulcer Drugs Consumption by Application (2015-2020) (K MT)

Table 38. Americas Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2015-2020)

Table 39. APAC Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020) (K MT)

Table 40. APAC Anti-Peptic Ulcer Drugs Consumption Market Share by Countries (2015-2020)

Table 41. APAC Anti-Peptic Ulcer Drugs Value by Regions (2015-2020) ($ Millions)

Table 42. APAC Anti-Peptic Ulcer Drugs Value Market Share by Regions (2015-2020)

Table 43. APAC Anti-Peptic Ulcer Drugs Consumption by Type (2015-2020) (K MT)

Table 44. APAC Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

Table 45. APAC Anti-Peptic Ulcer Drugs Consumption by Application (2015-2020) (K MT)

Table 46. APAC Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2015-2020)

Table 47. Europe Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020) (K MT)

Table 48. Europe Anti-Peptic Ulcer Drugs Consumption Market Share by Countries (2015-2020)

Table 49. Europe Anti-Peptic Ulcer Drugs Value by Countries (2015-2020) ($ Millions)

Table 50. Europe Anti-Peptic Ulcer Drugs Value Market Share by Countries (2015-2020)

Table 51. Europe Anti-Peptic Ulcer Drugs Consumption by Type (2015-2020) (K MT)

Table 52. Europe Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

Table 53. Europe Anti-Peptic Ulcer Drugs Consumption by Application (2015-2020) (K MT)

Table 54. Europe Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2015-2020)

Table 55. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Countries (2015-2020) (K MT)

Table 56. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Market Share by Countries (2015-2020)

Table 57. Middle East & Africa Anti-Peptic Ulcer Drugs Value by Countries (2015-2020) ($ Millions)

Table 58. Middle East & Africa Anti-Peptic Ulcer Drugs Value Market Share by Countries (2015-2020)

Table 59. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Type (2015-2020) (K MT)

Table 60. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

Table 61. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption by Application (2015-2020) (K MT)

Table 62. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2015-2020)

Table 63. Anti-Peptic Ulcer Drugs Distributors List

Table 64. Anti-Peptic Ulcer Drugs Customer List

Table 65. Global Anti-Peptic Ulcer Drugs Consumption Forecast by Countries (2021-2025) (K MT)

Table 66. Global Anti-Peptic Ulcer Drugs Consumption Market Forecast by Regions

Table 67. Global Anti-Peptic Ulcer Drugs Value Forecast by Countries (2021-2025) ($ Millions)

Table 68. Global Anti-Peptic Ulcer Drugs Value Market Share Forecast by Regions

Table 69. Global Anti-Peptic Ulcer Drugs Consumption Forecast by Type (2021-2025) (K MT)

Table 70. Global Anti-Peptic Ulcer Drugs Consumption Market Share Forecast by Type (2021-2025)

Table 71. Global Anti-Peptic Ulcer Drugs Value Forecast by Type (2021-2025) ($ Millions)

Table 72. Global Anti-Peptic Ulcer Drugs Value Market Share Forecast by Type (2021-2025)

Table 73. Global Anti-Peptic Ulcer Drugs Consumption Forecast by Application (2021-2025) (K MT)

Table 74. Global Anti-Peptic Ulcer Drugs Consumption Market Share Forecast by Application (2021-2025)

Table 75. Global Anti-Peptic Ulcer Drugs Value Forecast by Application (2021-2025) ($ Millions)

Table 76. Global Anti-Peptic Ulcer Drugs Value Market Share Forecast by Application (2021-2025)

Table 77. AstraZeneca Product Offered

Table 78. AstraZeneca Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 79. AstraZeneca Main Business

Table 80. AstraZeneca Latest Developments

Table 81. AstraZeneca Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 82. Xian Janssen Product Offered

Table 83. Xian Janssen Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 84. Xian Janssen Main Business

Table 85. Xian Janssen Latest Developments

Table 86. Xian Janssen Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 87. Ask-pharm Product Offered

Table 88. Ask-pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 89. Ask-pharm Main Business

Table 90. Ask-pharm Latest Developments

Table 91. Ask-pharm Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 92. Yangtze River Pharm Product Offered

Table 93. Yangtze River Pharm Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 94. Yangtze River Pharm Main Business

Table 95. Yangtze River Pharm Latest Developments

Table 96. Yangtze River Pharm Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 97. Shandong Luoxin Product Offered

Table 98. Shandong Luoxin Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 99. Shandong Luoxin Main Business

Table 100. Shandong Luoxin Latest Developments

Table 101. Shandong Luoxin Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 102. Takeda Product Offered

Table 103. Takeda Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 104. Takeda Main Business

Table 105. Takeda Latest Developments

Table 106. Takeda Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 107. Beijing Yuekang Product Offered

Table 108. Beijing Yuekang Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 109. Beijing Yuekang Main Business

Table 110. Beijing Yuekang Latest Developments

Table 111. Beijing Yuekang Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 112. Huadong Medicine Product Offered

Table 113. Huadong Medicine Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 114. Huadong Medicine Main Business

Table 115. Huadong Medicine Latest Developments

Table 116. Huadong Medicine Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 117. Guangdong Dahua Product Offered

Table 118. Guangdong Dahua Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 119. Guangdong Dahua Main Business

Table 120. Guangdong Dahua Latest Developments

Table 121. Guangdong Dahua Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

Table 122. Changzhou Siyao Product Offered

Table 123. Changzhou Siyao Anti-Peptic Ulcer Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2018-2020E)

Table 124. Changzhou Siyao Main Business

Table 125. Changzhou Siyao Latest Developments

Table 126. Changzhou Siyao Basic Information, Company Total Revenue (in $ million), Anti-Peptic Ulcer Drugs Manufacturing Base, Sales Area and Its Competitors

List of Figures

Figure 1. Picture of Anti-Peptic Ulcer Drugs

Figure 2. Anti-Peptic Ulcer Drugs Report Years Considered

Figure 3. Market Research Methodology

Figure 4. Global Anti-Peptic Ulcer Drugs Consumption Growth Rate 2015-2025 (K MT)

Figure 5. Global Anti-Peptic Ulcer Drugs Value Growth Rate 2015-2025 ($ Millions)

Figure 6. Product Picture of Proton Pump Inhibitors (PPIs)

Figure 7. Product Picture of Potassium-Competitive Acid Blockers (P-CAB)

Figure 8. Product Picture of Antacids

Figure 9. Product Picture of H2 Antagonists

Figure 10. Product Picture of Ulcer Protective Drugs

Figure 11. Global Anti-Peptic Ulcer Drugs Consumption Market Share by Type (2015-2020)

Figure 12. Global Anti-Peptic Ulcer Drugs Value Market Share by Type (2015-2020)

Figure 13. Anti-Peptic Ulcer Drugs Consumed in Gastritis

Figure 14. Global Anti-Peptic Ulcer Drugs Market: Gastritis (2015-2020) (K MT)

Figure 15. Global Anti-Peptic Ulcer Drugs Market: Gastritis (2015-2020) ($ Millions)

Figure 16. Anti-Peptic Ulcer Drugs Consumed in Gastric Ulcers

Figure 17. Global Anti-Peptic Ulcer Drugs Market: Gastric Ulcers (2015-2020) (K MT)

Figure 18. Global Anti-Peptic Ulcer Drugs Market: Gastric Ulcers (2015-2020) ($ Millions)

Figure 19. Anti-Peptic Ulcer Drugs Consumed in Duodenal Ulcers

Figure 20. Global Anti-Peptic Ulcer Drugs Market: Duodenal Ulcers (2015-2020) (K MT)

Figure 21. Global Anti-Peptic Ulcer Drugs Market: Duodenal Ulcers (2015-2020) ($ Millions)

Figure 22. Anti-Peptic Ulcer Drugs Consumed in Gastroesophageal Reflux Disease (GERD)

Figure 23. Global Anti-Peptic Ulcer Drugs Market: Gastroesophageal Reflux Disease (GERD) (2015-2020) (K MT)

Figure 24. Global Anti-Peptic Ulcer Drugs Market: Gastroesophageal Reflux Disease (GERD) (2015-2020) ($ Millions)

Figure 25. Global Anti-Peptic Ulcer Drugs Consumption Market Share by Application (2015-2020)

Figure 26. Global Anti-Peptic Ulcer Drugs Value Market Share by Application (2015-2020)

Figure 27. Global Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2017

Figure 28. Global Anti-Peptic Ulcer Drugs Sales Market Share by Company in 2019

Figure 29. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Company in 2017

Figure 30. Global Anti-Peptic Ulcer Drugs Revenue Market Share by Company in 2019

Figure 31. Global Anti-Peptic Ulcer Drugs Sale Price by Company in 2019

Figure 32. Global Anti-Peptic Ulcer Drugs Consumption Market Share by Regions 2015-2020

Figure 33. Global Anti-Peptic Ulcer Drugs Value Market Share by Regions 2015-2020

Figure 34. Americas Anti-Peptic Ulcer Drugs Consumption 2015-2020 (K MT)

Figure 35. Americas Anti-Peptic Ulcer Drugs Value 2015-2020 ($ Millions)

Figure 36. APAC Anti-Peptic Ulcer Drugs Consumption 2015-2020 (K MT)

Figure 37. APAC Anti-Peptic Ulcer Drugs Value 2015-2020 ($ Millions)

Figure 38. Europe Anti-Peptic Ulcer Drugs Consumption 2015-2020 (K MT)

Figure 39. Europe Anti-Peptic Ulcer Drugs Value 2015-2020 ($ Millions)

Figure 40. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption 2015-2020 (K MT)

Figure 41. Middle East & Africa Anti-Peptic Ulcer Drugs Value 2015-2020 ($ Millions)

Figure 42. Americas Anti-Peptic Ulcer Drugs Consumption Market Share by Countries in 2019

Figure 43. Americas Anti-Peptic Ulcer Drugs Value Market Share by Countries in 2019

Figure 44. Americas Anti-Peptic Ulcer Drugs Consumption Market Share by Type in 2019

Figure 45. Americas Anti-Peptic Ulcer Drugs Consumption Market Share by Application in 2019

Figure 46. United States Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 47. United States Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 48. Canada Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 49. Canada Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 50. Mexico Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 51. Mexico Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 52. APAC Anti-Peptic Ulcer Drugs Consumption Market Share by Countries in 2019

Figure 53. APAC Anti-Peptic Ulcer Drugs Value Market Share by Regions in 2019

Figure 54. APAC Anti-Peptic Ulcer Drugs Consumption Market Share by Type in 2019

Figure 55. APAC Anti-Peptic Ulcer Drugs Consumption Market Share by Application in 2019

Figure 56. China Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 57. China Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 58. Japan Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 59. Japan Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 60. Korea Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 61. Korea Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 62. Southeast Asia Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 63. Southeast Asia Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 64. India Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 65. India Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 66. Australia Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 67. Australia Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 68. Europe Anti-Peptic Ulcer Drugs Consumption Market Share by Countries in 2019

Figure 69. Europe Anti-Peptic Ulcer Drugs Value Market Share by Countries in 2019

Figure 70. Europe Anti-Peptic Ulcer Drugs Consumption Market Share by Type in 2019

Figure 71. Europe Anti-Peptic Ulcer Drugs Consumption Market Share by Application in 2019

Figure 72. Germany Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 73. Germany Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 74. France Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 75. France Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 76. UK Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 77. UK Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 78. Italy Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 79. Italy Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 80. Russia Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 81. Russia Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 82. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Market Share by Countries in 2019

Figure 83. Middle East & Africa Anti-Peptic Ulcer Drugs Value Market Share by Countries in 2019

Figure 84. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Market Share by Type in 2019

Figure 85. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption Market Share by Application in 2019

Figure 86. Egypt Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 87. Egypt Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 88. South Africa Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 89. South Africa Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 90. Israel Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 91. Israel Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 92. Turkey Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 93. Turkey Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 94. GCC Countries Anti-Peptic Ulcer Drugs Consumption Growth 2015-2020 (K MT)

Figure 95. GCC Countries Anti-Peptic Ulcer Drugs Value Growth 2015-2020 ($ Millions)

Figure 96. Global Anti-Peptic Ulcer Drugs Consumption Growth Rate Forecast (2021-2025) (K MT)

Figure 97. Global Anti-Peptic Ulcer Drugs Value Growth Rate Forecast (2021-2025) ($ Millions)

Figure 98. Americas Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 99. Americas Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 100. APAC Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 101. APAC Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 102. Europe Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 103. Europe Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 104. Middle East & Africa Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 105. Middle East & Africa Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 106. United States Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 107. United States Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 108. Canada Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 109. Canada Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 110. Mexico Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 111. Mexico Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 112. Brazil Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 113. Brazil Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 114. China Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 115. China Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 116. Japan Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 117. Japan Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 118. Korea Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 119. Korea Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 120. Southeast Asia Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 121. Southeast Asia Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 122. India Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 123. India Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 124. Australia Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 125. Australia Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 126. Germany Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 127. Germany Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 128. France Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 129. France Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 130. UK Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 131. UK Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 132. Italy Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 133. Italy Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 134. Russia Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 135. Russia Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 136. Spain Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 137. Spain Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 138. Egypt Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 139. Egypt Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 140. South Africa Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 141. South Africa Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 142. Israel Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 143. Israel Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 144. Turkey Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 145. Turkey Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 146. GCC Countries Anti-Peptic Ulcer Drugs Consumption 2021-2025 (K MT)

Figure 147. GCC Countries Anti-Peptic Ulcer Drugs Value 2021-2025 ($ Millions)

Figure 148. AstraZeneca Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 149. Xian Janssen Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 150. Ask-pharm Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 151. Yangtze River Pharm Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 152. Shandong Luoxin Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 153. Takeda Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 154. Beijing Yuekang Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 155. Huadong Medicine Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 156. Guangdong Dahua Anti-Peptic Ulcer Drugs Market Share (2018-2020)

Figure 157. Changzhou Siyao Anti-Peptic Ulcer Drugs Market Share (2018-2020)